ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
CP000832 |
|
555-30-6 |
Methyldopa - 99% |
0 | C10H13NO4 | |
CP002048 |
|
555-29-3 |
DL-Methyldopa - 99% |
0 | C10H13NO4 | |
CP003704 |
|
31645-35-9 |
Anthracen-9-ylmethyl methacrylate - 99% |
0 | C19H16O2 | |
CP005115 |
|
77883-43-3 |
Doxazosin Mesylate - 99% |
0 | C23H25N5O5.CH3SO3H;C24H | |
CP008255 |
|
35575-96-3 |
Azamethiphos - 99% |
0 | C9H10CLN2O5PS | |
CP004737 |
|
115956-07-5 |
(2a,6a,8a,9ab)-Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one - 98% |
0 | C10H15NO2 | |
CP002674 |
|
115956-13-3 |
Dolasetron mesylate - 98% |
0 | C20H24N2O6S | |
CP000041 |
|
115956-12-2 |
Dolasteron - 98% |
0 | C19H20N2O3 | |
CP007500 |
|
211914-51-1 |
3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methyl-benzoimidazole-5-carbonyl]-pyridin-2-yl-amino]propanoic acid - 98% |
0 | C25H25N7O3 | |
CP000580 |
|
211914-50-0 |
Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride - 99% |
0 | C27H29N7O3.HCL | |
CP004685 |
|
211915-84-3 |
Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate - 99% |
0 | C27H26N6O3 | |
CP007081 |
|
42288-26-6 |
2-((4-Cyanophenyl)amino)acetic acid - 98% |
0 | C9H8N2O2 | |
CP002216 |
|
212322-56-0 |
Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate - 99% |
0 | C18H22N4O3 | |
CP000221 |
|
112811-71-9 |
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester - ≥98.0% |
0 | C16H15F2NO4 | |
CP007356 |
|
112811-72-0 |
1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid - |
0 | C14H11NO4F2 | |
CP006844 |
|
1260590-51-9 |
N-Methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride - 98% |
0 | C13H19N5.HCL | |
CP007104 |
|
160738-57-8 |
Gatifloxacin hydrochloride - 99% |
0 | C19H23ClFN3O4 | |
CP000082 |
|
477600-75-2 |
Tofacitinib - 99% |
0 | C16H20N6O | |
CP007038 |
|
540737-29-9 |
Tofacitinib (Tasocitinib, CP-690550) - 99.61% |
0 | C16H20N6O.C6H8O7 | |
CP004061 |
|
1185-57-5 |
Ferric ammonium citrate;Ammonium ferric citrate - 98%-102% |
0 | C6H8FENO7 | |